AbbVie (ABBV)

$166.42 +2.07 (+1.26%)

Analyst Target Price $182.41 (+9.61%)

Analyst Rating Strong Buy 4

Analyst Rating Buy 14

Analyst Rating Hold 11

Analyst Rating Sell 0

Analyst Rating Strong Sell 0

Description:

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Exchange:

NYSE

Country:

USA

Sector:

LIFE SCIENCES

Industry:

PHARMACEUTICAL PREPARATIONS

Address:

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Fiscal year end:

December

Market capitalization:

$294 Billion

EBITDA:

$26.1 Billion

PERatio:

49.53

EPS:

3.36

Dividend per share:

$6.06

Dividend yield:

3.73%

Beta:

0.593

Dividends for 10 years

How much was you spent on shares:

$12 Thousand

How much will you earn in 10 years:

+32.19%

How much will you get:

$15.9 Thousand

Prices dates:

30-04-2014: $34.46 and 30-04-2024: $162.64